Shelley B Thunen
CIK 1297491 · See remarks · last filed 2025-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$206.4K
Companies
7
Total Filings
31
Lifetime Open-Market Net
-$8.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LENZ | Director | — | $6.77 | — | $0 | 1 | 2025-06-11 |
| AEON | Director | 36,021 | $0.72 | $25.8K | $0 | 2 | 2025-05-23 |
| RXST | See remarks | 38,354 | $4.71 | $180.6K | -$8.54M | 16 | 2025-04-15 |
| AEON Biopharma, Inc. (AEON.WS) Delisted | Director | — | $1.05 | — | $0 | 2 | 2024-03-21 |
| Venus Concept Inc. (HAIR) Delisted | Director | — | — | — | $0 | 1 | 2018-06-15 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Chief Financial Officer | 17,143 | — | — | $0 | 5 | 2015-10-21 |
| INTRALASE CORP (ILSE) Delisted | EVP & CFO | 32,548 | — | — | $0 | 2 | 2007-04-02 |
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-02 | RXST | Sell (S) | −20,000 | -$997.9K | EDGAR |
| 2024-03-25 | — | Grant (A) | — | $0 | |
| 2024-03-21 | AEON Biopharma, Inc. (AEON.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-06 | RXST | Grant (A) | — | $0 | EDGAR |
| 2024-03-05 | RXST | Mixed | — | -$407.7K | EDGAR |
| 2024-02-07 | RXST | Mixed | +6,900 | -$779.0K | EDGAR |
| 2024-01-29 | RXST | Mixed | +4,500 | -$998.1K | EDGAR |
| 2024-01-03 | RXST | Mixed | — | -$236.4K | EDGAR |
| 2023-12-18 | RXST | Mixed | −20,000 | -$1.26M | EDGAR |
| 2023-08-16 | AEON Biopharma, Inc. (AEON.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.